Lets start the Ball Rolling: AsiaPharm Group Ltd
Before i start: Let me set the frequency of my updating of this blog. I will TRY my very best to update this blog weekly (every fri or sat), simply because i am a NS man. So my book out is on the weekends la. After my Passing out, then maybe i can dedicate more time on updating this blog and hopefully can equip everyone with valuable information from all the readers.
And if you feel that this blog needs any improvement, please tell me on the comments or email me at miketong240286@gmail.com. Thanks =D
AsiaPharm Group Ltd
AsiaPharm Group Ltd. is a specialty pharmaceutical group in the Peoples Republic of China. It specializes in the research and development (R&D), production and sale of pharmaceutical drugs and formulations for chemical drugs, the sale of research and development results and patents for drugs, and the provision of research services on a contract basis. Its distribution network includes 35 sales support offices, covering 30 provinces, municipals and autonomous regions, reaching approximately 2,000 hospitals. Its core products include Lutingnuo, Maitongna, Nuosen, Okai, Sidinuo and Ximingting. In May 2006, the Company's wholly owned subsidiary, Shandong Luye Pharmaceutical Co., Ltd (Luye), acquired the remaining 20% minority interest in Luye's subsidiary, Yantai Luye Drugs Trading Co.
Their Management:
Dian Bo Liu > Group Executive Chairman of the Board
Chin Fan Chong > Chief Financial Officer
Hai Peng Diao > Vice President of Sales and Marketing
Yun Li Xue > Vice President - Research & Development
Ka Jia Su > Vice President-Administration, Human Resources and Information Technology
Chee Meng Wong > Company Secretary Officer Since: 04/29/2006
Poh Noi Yeo > Company Secretary
Hui Xian Yuan > Executive Director
Ke Liu > Chief Scientific Officer
And if you feel that this blog needs any improvement, please tell me on the comments or email me at miketong240286@gmail.com. Thanks =D
AsiaPharm Group Ltd
AsiaPharm Group Ltd. is a specialty pharmaceutical group in the Peoples Republic of China. It specializes in the research and development (R&D), production and sale of pharmaceutical drugs and formulations for chemical drugs, the sale of research and development results and patents for drugs, and the provision of research services on a contract basis. Its distribution network includes 35 sales support offices, covering 30 provinces, municipals and autonomous regions, reaching approximately 2,000 hospitals. Its core products include Lutingnuo, Maitongna, Nuosen, Okai, Sidinuo and Ximingting. In May 2006, the Company's wholly owned subsidiary, Shandong Luye Pharmaceutical Co., Ltd (Luye), acquired the remaining 20% minority interest in Luye's subsidiary, Yantai Luye Drugs Trading Co.
Their Management:
Dian Bo Liu > Group Executive Chairman of the Board
Chin Fan Chong > Chief Financial Officer
Hai Peng Diao > Vice President of Sales and Marketing
Yun Li Xue > Vice President - Research & Development
Ka Jia Su > Vice President-Administration, Human Resources and Information Technology
Chee Meng Wong > Company Secretary Officer Since: 04/29/2006
Poh Noi Yeo > Company Secretary
Hui Xian Yuan > Executive Director
Ke Liu > Chief Scientific Officer
What are your views on this company?
Which company next?
No comments:
Post a Comment